In after-hours trading, shares are down 42% to $1.20 Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on HEPA: Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial Hepion Pharmaceuticals appoints Purcell to board of directors Hepion Pharmaceuticals Strengthens Board of Directors with Appointment of Michael Purcell